Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC).
about
Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Paired tumor biopsy analysis a ...... epatocellular carcinoma (HCC).
@en
Paired tumor biopsy analysis a ...... with hepatocellular carcinoma
@nl
type
label
Paired tumor biopsy analysis a ...... epatocellular carcinoma (HCC).
@en
Paired tumor biopsy analysis a ...... with hepatocellular carcinoma
@nl
prefLabel
Paired tumor biopsy analysis a ...... epatocellular carcinoma (HCC).
@en
Paired tumor biopsy analysis a ...... with hepatocellular carcinoma
@nl
P2093
P1476
Paired tumor biopsy analysis a ...... hepatocellular carcinoma (HCC)
@en
P2093
Aradhana Venkatesan
Austin Duffy
David E Kleiner
Kathryn Compton
Melissa Walker
Metin Kurtoglu
Nadine Abi-Jaoudeh
Oxana Rusher
Sid P Kerkar
Suzanne Fioravanti
P2888
P304
P356
10.1186/2051-1426-2-S3-P98
P433
P577
2014-11-06T00:00:00Z
P5875
P6179
1029173904